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THE SYNTHESIS OF A CYCLIC PEPTIDE LffiRARY FOR THE 
DISCOVERY OF SICKLE-CELL HEMOGLOBIN LIGANDS 
Jeremy Henle and Brian Brennan* 
Chemistry Department, Illinois Wesleyan University 
Sickle Cell Disease is a genetically inherited blood disorder that leads to the aggregation of 
hemoglobin, the oxygen transport protein in the body. This aggregation leads to the formation of 
the characteristic sickle shape of the red blood cells, which is the cause of the symptoms of the 
disease. There are currently few treatments for this disorder, with the only cure being a risky 
bone marrow transplant. My research is focused on trying to find compounds that bind to Sickle 
.Cell hemoglobin in such a way that this aggregation is prevented. One method is to use peptides 
that bind at the interface of the aggregated hemoglobin. Unfortunately, the use of linear peptides 
. suffers from many drawbacks, including low cell permeability and poor stability in the cellular 
environment. To circumvent these problems, my work focuses on the use of cyclic peptides to 
inhibit hemoglobin aggregation. In order to discover cyclic peptides that bind to Sickle Cell 
hemoglobin, lam synthesizing a focused, cyclic peptide library of 160,000 different peptide 
sequences. After synthesizing the library, an assay will be performed to determine if any of the 
constructed cyclic peptides bind to hemoglobin. These ligands may represent the next generation 
of therapeutics for this debilitating disorder. 
